Shanghai Epidemiology Study for Adolescents and Children With Cancer

February 9, 2024 updated by: Children's Cancer Group, China
The purpose of this study is to describe the morbidity, mortality, disability and survival rate in Shanghai adolescents and children with cancer diagnosed since January 2002.

Study Overview

Status

Recruiting

Conditions

Detailed Description

The investigators collected information of all the adolescents and children diagnosed cancer in Shanghai since January 2002, including their name, gender, the date of birth, the diagnosis date, disease diagnosis, residence address and the last follow-up time status (survival/death). The type of cancer included all malignant tumors such as Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Non-Hodgkin Lymphoma, Hodgkin Lymphoma, central nervous system tumors, Neuroblastoma, Wilms tumor and so on. Then the investigators would analyze the morbidity, mortality, disability and survival rate.

Study Type

Observational

Enrollment (Estimated)

2000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Shanghai
      • Shanghai, Shanghai, China, 200127
        • Active, not recruiting
        • Shanghai Children's Medical Center
      • Shanghai, Shanghai, China, 200336
        • Recruiting
        • Shanghai Municipal Center of Disease Prevention & Control
        • Contact:
          • Ying Zheng, MS,MD
          • Phone Number: 0086-21-62758710
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 second to 19 years (Child, Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Since January 2002 in Shanghai, 0-19 year-old children and adolescents diagnosed with cancer.

Description

Inclusion Criteria:

  • 0-19 year-old children and adolescents.
  • Diagnosed cancer in Shanghai since January 2002.

Exclusion Criteria:

  • Patients who were lost of follow-up.
  • Patient's death wasn't caused by cancer or complications but by other accidents such as car accident, fell from a great height and so on.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
1
Patients were diagnosed since January 2002.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Overall survival for the whole cohort
Time Frame: 5 years
5 years

Secondary Outcome Measures

Outcome Measure
Time Frame
Mortality for the whole cohort
Time Frame: 5 years
5 years

Other Outcome Measures

Outcome Measure
Time Frame
Disability rate for the whole cohort
Time Frame: 5 years
5 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Yi-Jin Gao, MD, Shanghai Children's Medical Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2002

Primary Completion (Actual)

April 1, 2017

Study Completion (Estimated)

January 1, 2030

Study Registration Dates

First Submitted

November 7, 2016

First Submitted That Met QC Criteria

November 7, 2016

First Posted (Estimated)

November 8, 2016

Study Record Updates

Last Update Posted (Actual)

February 12, 2024

Last Update Submitted That Met QC Criteria

February 9, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • CCGChina

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Childhood Cancer

3
Subscribe